Outlining the implications of this c-suite trend for pharma.
Michael Abrams, MA
Advertisement
Articles by Michael Abrams, MA
Commercial-model shift demanding greater influence of these teams.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
3
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
4
Hiring and Fostering Top Talent
5